ARGENX SE is 38.3x more valuable than Vir Biotechnology, Inc. by market capitalization ($53.35 B vs $1.39 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | VIR | ARGX |
|---|---|---|
| Market cap | $1.39 B | $53.35 B |
| US-listed rank | #2385 | #306 |
| Revenue (latest FY) | $68.56M | - |
| Net income (latest FY) | -$437.99M | - |
| Net margin | -638.9% | - |
| SEC filings | 762 | 272 |
ARGENX SE is 38.3x more valuable than Vir Biotechnology, Inc. by market capitalization ($53.35 B vs $1.39 B).
Full pages: Vir Biotechnology, Inc. and ARGENX SE, or browse the full rankings.